Evotec SE (EVO) Total Current Liabilities (2009 - 2026)
Evotec SE (EVO) reported Total Current Liabilities of $495663.3 for Q1 2026, up 32.02% on a YoY basis from $375438.6 in Q1 2025, and up 15.69% sequentially from $428454.2 in Q4 2025.
Evotec SE (EVO) Total Current Liabilities (2009 - 2026) Analysis & Trends
Evotec SE (EVO) has 9 years of Total Current Liabilities data on file, last reported at $495663.3 in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 32.02% year-over-year to $495663.3; the trailing twelve-month figure through Mar 2026 stood at $495663.3 (up 32.02% YoY), and the FY2025 full-year result was $428454.2, down 99.88% from the prior year.
- Total Current Liabilities climbed to $495663.3 in Q1 2026, from $428454.2 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $499.9 million in Q4 2023 to a low of $343621.9 in Q3 2022.
- A 5-year average of $110.5 million and a median of $433750.0 in 2025 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities jumped 45.08% in 2023 and slumped 99.88% in 2025, its largest moves.
- Tracing EVO's Total Current Liabilities over 5 years: stood at $344.5 million in 2022, then jumped by 45.08% to $499.9 million in 2023, then slipped by 26.33% to $368.2 million in 2024, then tumbled by 99.88% to $428454.2 in 2025, then gained by 15.69% to $495663.3 in 2026.
- Business Quant data shows EVO's Total Current Liabilities at $495663.3 in Q1 2026, $428454.2 in Q4 2025, and $437772.6 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | 495,663.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 495,663.27 |
| Dec 31, 2025 | 428,454.15 |
| Sep 30, 2025 | 437,772.55 |
| Jun 30, 2025 | 433,749.97 |
| Mar 31, 2025 | 375,438.59 |
| Dec 31, 2024 | 368.22 Mn |
| Sep 30, 2024 | 366,385.79 |
| Dec 31, 2023 | 499.85 Mn |
| Dec 31, 2022 | 344.54 Mn |
| Sep 30, 2022 | 343,621.91 |
| Mar 31, 2022 | 381,168.34 |
| Dec 31, 2021 | 371.24 Mn |
| Sep 30, 2021 | 299,277.18 |
| Dec 31, 2020 | 248.54 Mn |
| Sep 30, 2010 | 35,831.52 |
| Jun 30, 2010 | 32,220.24 |
| Mar 31, 2010 | 32.97 |
| Dec 31, 2009 | 39,052.24 |
| Aug 31, 2009 | 1,102.77 |
| Jun 30, 2009 | 31.95 Mn |